HMCIB SPAC 3 (226340) - Total Liabilities
Based on the latest financial reports, HMCIB SPAC 3 (226340) has total liabilities worth ₩29.73 Billion KRW (≈ $20.15 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see 226340 current and non-current assets.
HMCIB SPAC 3 - Total Liabilities Trend (2015–2023)
This chart illustrates how HMCIB SPAC 3's total liabilities have evolved over time, based on quarterly financial data. Explore 226340 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
HMCIB SPAC 3 Competitors by Total Liabilities
The table below lists competitors of HMCIB SPAC 3 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yapi Kredi Koray Gayrimenkul Yatirim Ortakligi AS
IS:KGYO
|
Turkey | TL7.58 Billion |
|
SR Accord
TA:SRAC
|
Israel | ILA1.42 Billion |
|
Legal & General Group PLC
LSE:LGEN
|
UK | GBX610.73 Billion |
|
Conduent Inc
NASDAQ:CNDT
|
USA | $1.57 Billion |
|
Nordic Aqua Partners As
OL:NOAP
|
Norway | Nkr92.92 Million |
|
Pioneer Municipal High Income Advantage Trust
NYSE:MAV
|
USA | $51.06 Million |
|
SEEING MACHINES LTD
F:M2Z
|
Germany | €88.34 Million |
|
Bursa Cimento Fabrikasi AS
IS:BUCIM
|
Turkey | TL10.32 Billion |
Liability Composition Analysis (2015–2023)
This chart breaks down HMCIB SPAC 3's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check financial resilience of HMCIB SPAC 3 to evaluate the company's liquid asset resilience ratio.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HMCIB SPAC 3's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HMCIB SPAC 3 (2015–2023)
The table below shows the annual total liabilities of HMCIB SPAC 3 from 2015 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | ₩47.65 Billion ≈ $32.29 Million |
-19.20% |
| 2022-12-31 | ₩58.97 Billion ≈ $39.96 Million |
-3.55% |
| 2021-12-31 | ₩61.14 Billion ≈ $41.43 Million |
+178.69% |
| 2020-12-31 | ₩21.94 Billion ≈ $14.87 Million |
+208.43% |
| 2019-12-31 | ₩7.11 Billion ≈ $4.82 Million |
-25.38% |
| 2018-12-31 | ₩9.53 Billion ≈ $6.46 Million |
+891.73% |
| 2017-12-31 | ₩961.20 Million ≈ $651.39K |
+3.41% |
| 2016-12-31 | ₩929.50 Million ≈ $629.91K |
+3.73% |
| 2015-12-31 | ₩896.04 Million ≈ $607.24K |
-- |
About HMCIB SPAC 3
Bonne Co., Ltd. develops and supplies cosmetics in South Korea. The company offers skin care products, including whitening, wrinkle and pimple treatment, stem-cell peptide, and nano peptide products; and sun care products comprising fluids, creams, emulsions, etc. It also provides hair and body care products; makeup products, such as foundation, powder, compact, loose powder, BB cream, eye liner,… Read more